Same-day lymphoscintigraphy and sentinel node biopsy for early breast cancer

ANZ Journal of Surgery

Volumn 72, Issue 8, 2002, Pages 542-546

  Sutton, Richard ^a   Kollias, James ^a,b   Prasad, Varni ^a,b   Chatterton, Barry ^a   Grantley Gill, P ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Breast cancer; Lymphoscintigraphy; Sentinel node biopsy

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M; RADIOISOTOPE; TECHNETIUM;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER LOCALIZATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIONUCLIDE IMAGING; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS;

EID: 0036040755     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2002.02482.x     Document Type: Article

References (16)

1. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
2. The reliability of sentinel node status in predicting axillary lymph node involvement in breast cancer
3. Clinical and histological factors associated with sentinel node identification in breast cancer
4. Lymphatic mapping and sentinel node biopsy in breast cancer
5. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative nodes
6. Sentinel lymphadenectomy for breast cancer: Experience with 180 consecutive patients: Efficacy of filtered technetium 99m sulphur colloid with overnight migration time
7. Gamma probe-guided sentinel node biopsy - Optimal timing for injection
8. In search of the true sentinel node by different injection techniques in breast cancer patients
9. 99mTC-labeled Dextran
10. Development of sentinel node targeting technique in breast cancer patients
11. Variability of cutaneous lymphatic flow rates
12. Particle size analysis of (99m) Tc-labeled and unlabeled antimony trisulfide and rhenium sulfide colloids intended for lymphoscintigraphic application
13. Lymphoscintigraphy and sentinel node localization in breast cancer patients: A comparison between 1-day and 2-day protocols
14. Learning sentinel node biopsy: Results of a prospective randomized trial of two techniques